news
A study of the SARS-CoV-2 nonstructural protein 1 (Nsp1) showed…
20 July 2020 | By Hannah Balfour (Drug Target Review)
A study of the SARS-CoV-2 nonstructural protein 1 (Nsp1) showed it can supress translation and inhibit anti-viral defence mechanisms, making it a potential target for drugs.